Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma 1

Interventions

Cyclophosphamide 30 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 21 Prednisone 20 Etoposide 20 Vincristine 16 Whole-Body Irradiation 15 Doxorubicin 15 fludarabine phosphate 14 Peripheral Blood Stem Cell Transplantation 14 romidepsin 13 Mycophenolic Acid 12 Lenalidomide 12 Gemcitabine 12 Cyclosporine 10 Azacitidine 10 Brentuximab Vedotin 9 Bortezomib 9 Alemtuzumab 8 Dexamethasone 7 Methotrexate 6 Cytarabine 6 Busulfan 6 Carmustine 5 pembrolizumab 4 fludarabine 4 Vorinostat 4 Tacrolimus 4 Rituximab 4 Melphalan 4 Ifosfamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, T-Cell, Peripheral × CHOP protocol × Clear all

NCT00970385 2009-09-09

LTP

University Hospital, Grenoble

Phase 3 Completed

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡